Early treatment may let PAH patients scale back infusions over time

People with severe pulmonary arterial hypertension (PAH) who respond well to early treatment with prostacyclin infusions may be able to reduce or stop the treatment, a study suggested. In a long-term analysis of 101 patients, about one in five achieved enough improvement in heart and lung blood flow measurements to gradually discontinue this therapy, with […] The post Early treatment may let PAH…